Lion Capital S.A. is a Romania-based closed-end alternative investment fund and asset management company operating as a self-managed Alternative Investment Fund Manager (AIFM) and Alternative Investment Fund for Retail Investors (AIFRI). Founded in 1996 upon the restructuring of the Banat-Crișana Private Property Fund (originally established in 1992) and headquartered in Bucharest, Romania, with a secondary administrative office in Arad, the company specializes in managing a diversified portfolio of financial assets and long-term equity participations. The company's core operations and services encompass alternative investment fund management; active portfolio asset management across public and private equity markets; equity investments in the banking and financial intermediation sector, notably through major holdings in commercial lenders such as Banca Transilvania and BRD - Groupe Société Générale; pharmaceutical and healthcare equity management, primarily through a controlling stake in manufacturer Biofarm S.A.; real estate asset management and development through dedicated property vehicles, including SIF Imobiliare PLC and SIF1 IMGB; industrial manufacturing and engineering investments, including equity positions in IAMU S.A. and Vrancart S.A.; energy, utilities, and natural resource asset allocations, encompassing equity positions in producers such as OMV Petrom; asset management services through its subsidiary SAI Muntenia Invest S.A., which manages the assets of Longshield Investment Group; corporate restructuring, strategic governance, and board-level advisory for portfolio holdings; and treasury management across fixed-income instruments, bonds, and money market assets. Lion Capital primarily caters to domestic and international institutional investors, retail shareholders, and corporate entities across Romania and Central and Eastern Europe, trading publicly on the Premium tier of the Bucharest Stock Exchange under the ticker symbol LION. In recent corporate developments, the company completed a comprehensive corporate rebranding, changing its name from SIF Banat-Crișana S.A. to Lion Capital S.A. and transitioning its trading ticker from SIF1 to LION. Operationally, the company formally relocated its registered headquarters from Arad to Bucharest following regulatory and shareholder approvals. Strategically, Lion Capital has advanced portfolio consolidation and value-realization measures, including implementation agreements regarding the voluntary public takeover offer and strategic alignment for pharmaceutical subsidiary Biofarm S.A., continued repositioning and master planning of major brownfield and urban real estate assets in Bucharest, and the execution of share buyback and capital reallocation programs to enhance shareholder value and optimize asset allocation across its core sectors.